Citation: Sj. Pelletier et al., Improved outcome for HCV recipients with normal serum transaminases after liver transplantation, TRANSPLAN P, 33(1-2), 2001, pp. 1397-1398
Authors:
Caldwell, SH
Hespenheide, EE
Redick, JA
Iezzoni, JC
Battle, EH
Sheppard, BL
Citation: Sh. Caldwell et al., A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis, AM J GASTRO, 96(2), 2001, pp. 519-525
Citation: Sj. Pelletier et al., Prediction of liver allograft fibrosis after transplantation for hepatitisc virus: Persistent elevation of serum transaminase levels versus necroinflammatory activity, LIVER TRANS, 6(1), 2000, pp. 44-53
Citation: Sj. Pelletier et al., Pretransplantation hepatitis C virus quasispecies may be predictive of outcome after liver transplantation, HEPATOLOGY, 32(2), 2000, pp. 375-381
Citation: Sj. Pelletier et al., Hepatitis C-induced hepatic allograft injury is associated with a pretransplantation elevated viral replication rate, HEPATOLOGY, 32(2), 2000, pp. 418-426
Authors:
Iezzoni, JC
Mills, SE
Pelkey, TJ
Stoler, MH
Citation: Jc. Iezzoni et al., Inhibin is not an immunohistochemical marker for hepatocellular carcinoma - An example of the potential pitfall in diagnostic immunohistochemistry caused by endogenous biotin, AM J CLIN P, 111(2), 1999, pp. 229-234
Authors:
Caldwell, SH
Oelsner, DH
Iezzoni, JC
Hespenheide, EE
Battle, EH
Driscoll, CJ
Citation: Sh. Caldwell et al., Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease, HEPATOLOGY, 29(3), 1999, pp. 664-669